CARLEY MCLAUGHLIN: Open Payments
NPI 1265090930 · EDMOND, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$978 in 53 payments from 16 companies in 2025. Trend: 2023 $515 · 2024 $1,042 · 2025 $978
Food & beverage: $978
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $185 |
| PFIZER INC. | 10 | $168 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $146 |
| Corcept Therapeutics | 8 | $146 |
| SHIELD THERAPEUTICS INC | 2 | $55 |
| Lilly USA, LLC | 2 | $49 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| Intra-Sana Laboratories | 2 | $38 |
| Kowa Pharmaceuticals America, Inc. | 1 | $23 |
| IBSA Pharma Inc. | 1 | $22 |
Products named: NURTEC ODT, TRINTELLIX, Korlym, UBRELVY, ACCRUFER, VRAYLAR, REXULTI, RELTONE 200 MG.
Industry payments across OK — which companies pay providers there.
